Modulation of p38 MAPK signaling in spinal cord injury by curcumin: targeting inflammation, oxidative stress, and apoptosis
Inflammopharmacology · 2026
DOI: 10.1007/s10787-026-02405-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2026. Verfasst von Shokoufeh Rahmani und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Curcumin, Spinal Cord Injuries, Oxidative Stress, p38 Mitogen-Activated Protein Kinases. Die Arbeit nennt 176 Literaturangaben.
Abstract (Originalsprache)
Spinal cord injury (SCI) triggers a complex secondary injury cascade characterized by neuroinflammation, oxidative stress, and programmed cell death, in which p38 mitogen-activated protein kinase (MAPK) signaling has emerged as an important regulatory node. Curcumin, a pleiotropic polyphenol derived from Curcuma longa, has attracted considerable interest as a potential neuroprotective agent because of its anti-inflammatory, antioxidant, and anti-apoptotic properties. Accumulating preclinical evidence suggests that curcumin can modulate p38 MAPK-associated signaling, attenuate inflammatory mediator production, reduce oxidative damage, and improve histological and functional outcomes in experimental SCI. In addition to p38-related effects, curcumin has also been reported to influence interconnected pathways involved in cell survival, gliosis, and stress responses. However, the available literature remains heterogeneous with respect to injury models, formulations, dosing strategies, and outcome measures. Overall, curcumin appears to be a promising adjunctive candidate for limiting secondary injury after SCI, but further mechanistic clarification and improved delivery strategies will be required to enhance translational relevance and support future clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. Aroma3162@gmail.com.
- Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Aroma3162@gmail.com.
- Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Aroma3162@gmail.com.
- Department of Faculty and Hospital Surgery, Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan.
- Division of Engineering in Medicine, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Cambridge, MA, USA.
Zitieren
APA
Rahmani, S., Gholami Abroumand, A., Davlatov, S., Mortazavi Moghadam, F., Kolaeva, N. V., Tahmasebi, F., Babaloo, H., Yakutkhon, M., & Rakhmanov, K. (2026). Modulation of p38 MAPK signaling in spinal cord injury by curcumin: targeting inflammation, oxidative stress, and apoptosis. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02405-0
Vancouver
Rahmani S, Gholami Abroumand A, Davlatov S, Mortazavi Moghadam F, Kolaeva NV, Tahmasebi F, et al. Modulation of p38 MAPK signaling in spinal cord injury by curcumin: targeting inflammation, oxidative stress, and apoptosis. Inflammopharmacology. 2026. doi:10.1007/s10787-026-02405-0
BibTeX
@article{Rahmani2026,
author = {Rahmani, Shokoufeh and Gholami Abroumand, Arman and Davlatov, Salim and Mortazavi Moghadam, Fatemeh and Kolaeva, Natalia V and Tahmasebi, Fatemeh and Babaloo, Hamideh and Yakutkhon, Madjidova and Rakhmanov, Kosim},
title = {Modulation of p38 MAPK signaling in spinal cord injury by curcumin: targeting inflammation, oxidative stress, and apoptosis},
journal = {Inflammopharmacology},
year = {2026},
doi = {10.1007/s10787-026-02405-0}
}
EUVIMED